A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning
WCCB CharlotteBy Associated PressOctober 23, 2026
Originally published by WCCB Charlotte. The summary below is provided for informational purposes. Read the full article on their website.
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Read the complete story on the original publisher's website
Read the Full Story at WCCB Charlotte